Latest News
-
175% Dividend: TATA Group Stock Declares Q4 Results; Buy The Rekha Jhunjhunwala Portfolio Stock? -
2:15 Bonus: Tata Group's Penny Stock Below Rs 90, Gives 2,821% Returns In 5 Years: Announces Q4 Report Card -
Rs. 240/Share Dividend: May 7 Fixed As Record Date; Buy The IT Stock To Be Eligible? -
1:5 & 1:2 Split, Rs 6/Sh Dividend: Fertilizer Stock Coming Up With 600% Payout; Record, Payment Dates Fixed -
Cube Highways Trust Set to Acquire Seven Highway Assets Worth Rs 5,172 Crore -
1:10 Split, Rs 51 Dividend: Accumulate Tata Stock, TP Rs 170; Big Update On £1.25 Bn Investment -
Tech Mahindra Sets Three-Year Plan for Robust Growth and Market Leadership by FY27 -
Tech Mahindra Q4 Net Profit Falls 41%, Announces Growth Strategy -
3 Bonus, 1:2 Split, 38 Dividends: Rs 1,915 Midcap IT Stock To Pay 360% Dividend After Q4 Profit Rises -
EU Finds No New ETO Cases in Indian Organic Exports Post-Dec 2020
Tatva Chintan Pharma IPO: Check Price Band, IPO Dates, Other Details
Tatva Chintan Pharma Chem Ltd is one of the fastest-growing specialty chemical manufacturers in the world. Structure Directing Agents (SDAs), Phase Transfer Catalysts (PTCs), Electrolyte Salts for supercapacitor batteries, Pharmaceutical and Agrochemical Intermediates, and other Specialty Chemicals are among our extensive product offerings. They are situated in Gujarat and are one of the leading manufacturers of SDAs for zeolites in India.
Tatva Chintan Pharma IPO details
The price band for the sale has been set at Rs 1,073-1,083 per equity share. The company seeks to raise Rs 500 crore through an IPO that includes a Rs 225 crore new issuance and a Rs 275 crore offer for sale by existing selling shareholders. Its book-running main managers are ICICI Securities and JM Financials. The offer's registrar is Link Intime India.
Chintan Shah, Ajay Patel, and Shekhar Somani are the people behind Tatva Chintan.
| IPO Open Date | Jul 16, 2021 |
| IPO Close Date | Jul 20, 2021 |
| Jul 20, 2021 | Jul 26, 2021 |
| Initiation of Refunds | Jul 27, 2021 |
| Credit of Shares to Demat Account | Jul 28, 2021 |
| IPO Listing Date | Jul 29, 2021 |
Investors can place bids for as few as 13 equity shares and as many as they want. They will have to pay Rs 14,079 for a single lot at the top price range. In the Tatva Chintan Pharma Chem IPO, 50% of the shares will be allocated for qualified institutional buyers (QIBs) and 15% for non-institutional investors (NIIs).
Apart from Indian customers, the company exports to over 25 nations, including the United States, China, Germany, Japan, South Africa, and the United Kingdom. Exports of products totaled Rs 211.99 crore in FY21, accounting for 70.58 percent of total revenue from operations.
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹1073 to ₹1083 per equity share |
| Market Lot | 13 Shares |
After Clean Science & Technology, Laxmi Organic Industries, and Anupam Rasayan India, this is the fourth specialty firm to go public in 2021.
How to apply for Tatva Chintan Pharma's first public offering?
You can apply online for Tatva Chintan Pharma IPO utilizing UPI or ASBA as a payment option. The ASBA IPO application can be found in your bank account's net banking. Brokers who do not provide banking services provide the UPI IPO application.
